I agree that this site is using cookies. You can find further informations here.
X
Ghiringhelli, F.
332  results:
Search for persons X
?
1

31P Effect of fruquintinib in patients with heavily pretrea..:

Tabernero, J. ; Eng, C. ; Lonardi, S....
Annals of Oncology.  35 (2024)  - p. S15-S16 , 2024
Link: https://doi.org/10.1016/..
 
?
2

116P Angiopietin-2 (Ang-2) as a potential biomarker for gui..:

Borg, C. ; Dourthe, L-M. ; André, T....
Annals of Oncology.  35 (2024)  - p. S54-S55 , 2024
Link: https://doi.org/10.1016/..
 
?
3

54P Phase I dose-escalation study of trifluridine/tipiracil..:

Roussot, N. ; Thibaudin, M. ; Burlot, C....
Annals of Oncology.  35 (2024)  - p. S26 , 2024
Link: https://doi.org/10.1016/..
 
?
4

22O Association of biomarkers with response to coformulated..:

Le Tourneau, C. ; Rojas, C.I. ; Leary, A....
ESMO Open.  9 (2024)  - p. 103522 , 2024
Link: https://doi.org/10.1016/..
 
?
5

159TiP COPERNIC: A study of on-treatment circulating tumour..:

Assaf, I. ; Bregni, G. ; Anthoine, G....
Annals of Oncology.  35 (2024)  - p. S70-S71 , 2024
Link: https://doi.org/10.1016/..
 
?
6

21O Coformulated vibostolimab/pembrolizumab in advanced cer..:

Leary, A. ; Yonemori, K. ; Le Tourneau, C....
ESMO Open.  9 (2024)  - p. 103521 , 2024
Link: https://doi.org/10.1016/..
 
?
7

43P Single-arm phase II of desynchronized irinotecan plus b..:

Ghiringhelli, F. ; Roussot, N. ; Bertaut, A....
Annals of Oncology.  35 (2024)  - p. S21-S22 , 2024
Link: https://doi.org/10.1016/..
 
?
8

25P Patient-reported outcomes (PROs) with coformulated vibo..:

Yonemori, K. ; Rojas, C.I. ; Leary, A....
ESMO Open.  9 (2024)  - p. 103525 , 2024
Link: https://doi.org/10.1016/..
 
?
9

KS01.6.A UCPVAX-GLIO: A PHASE II TRIAL EVALUATING THE IMMUN..:

Carpentier, A F ; Verlut, C ; Ghiringhelli, F...
Neuro-Oncology.  25 (2023)  Supplement_2 - p. ii3-ii4 , 2023
Link: https://doi.org/10.1093/..
 
?
10

185P Interim analysis of the EOGBM1-18 study: Strong immune..:

Wick, W. ; Gamelas Magalhaes, J. ; Dos Santos Leite, A.M....
Immuno-Oncology and Technology.  16 (2022)  - p. 100297 , 2022
Link: https://doi.org/10.1016/..
 
?
11

170P EO2401 microbiome derived therapeutic vaccine + nivolu..:

Wick, W. ; IdBaih, A. ; Vieito Villar, M....
Immuno-Oncology and Technology.  16 (2022)  - p. 100282 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Weakly Supervised Learning using Attention gates for colon ..:

Ben Hamida, A. ; Devanne, M. ; Weber, J....
Artificial Intelligence in Medicine.  133 (2022)  - p. 102407 , 2022
Link: https://doi.org/10.1016/..
 
?
13

EE608 Cost Effectiveness Analysis of a Large (Foundation Me..:

Perrier, L ; Tredan, O ; Morelle, M...
Value in Health.  25 (2022)  12 - p. S175 , 2022
Link: https://doi.org/10.1016/..
 
?
14

PL02.1.A EO2401, a novel microbiome-derived therapeutic vac..:

Idbaih, A ; Vieito, M ; Tabatabai, G...
Neuro-Oncology.  24 (2022)  Supplement_2 - p. ii2-ii2 , 2022
Link: https://doi.org/10.1093/..
 
?
15

Deep learning for colon cancer histopathological images ana..:

Ben Hamida, A. ; Devanne, M. ; Weber, J....
Computers in Biology and Medicine.  136 (2021)  - p. 104730 , 2021
Link: https://doi.org/10.1016/..
 
1-15